FFCP PHASE1:Mm9::chr17:48386911..48386918,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=58218|HGNC=|MCL_coexpression_id=3|UniProt=Q9JKE1|association_with_transcript=-25bp_to_ENSMUST00000048065,NM_021407,uc008cwy.1_5end|description=CAGE_peak_6_at_Trem3_5end|id=chr17:48386911..48386918,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,3.38e-13,9|ontology_enrichment_disease=DOID:0060100!3.99e-17!3;DOID:4045!3.99e-17!3;DOID:0050686!7.98e-09!6|ontology_enrichment_disease_v019_2=DOID:0060100,6.64e-38,3;DOID:4045,6.64e-38,3;DOID:0050686,2.11e-19,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.38e-13,9;UBERON:0002036,3.38e-13,9;UBERON:0002385,3.38e-13,9;UBERON:0000486,3.38e-13,9;UBERON:0007503,3.38e-13,9;UBERON:0001015,3.38e-13,9;UBERON:0002329,3.38e-13,9;UBERON:0003082,3.38e-13,9;UBERON:0003059,3.38e-13,9;UBERON:0007282,3.38e-13,9;UBERON:0004290,3.38e-13,9;UBERON:0009618,3.38e-13,9;UBERON:0000383,5.96e-12,10;UBERON:0007524,6.27e-11,11;UBERON:0003077,6.27e-11,11;UBERON:0007285,6.27e-11,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.95210098400125,4.6880120671428,9.94695113550217,9.99993529652724,6.14740936462601,8.25367600152961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.884610551949874,0,0,0,0,0,0,0,0.11981512450592,0.599902730993408,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.28673953557358,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.287696137450811,0.162135226775035,0.274561413188081,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100826185136841,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p6@Trem3}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=58218 | |||
|HGNC= | |||
|MCL_coexpression_id=3 | |||
|TSSclassifier=NA | |||
|UniProt=Q9JKE1 | |||
|association_with_transcript=-25bp_to_ENSMUST00000048065,NM_021407,uc008cwy.1_5end | |||
|cluster_id=chr17:48386911..48386918,+ | |||
|description=CAGE_peak_6_at_Trem3_5end | |||
|id=chr17:48386911..48386918,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,3.38e-13,9 | |||
|ontology_enrichment_disease=DOID:0060100!3.99e-17!3;DOID:4045!3.99e-17!3;DOID:0050686!7.98e-09!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,6.64e-38,3;DOID:4045,6.64e-38,3;DOID:0050686,2.11e-19,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.38e-13,9;UBERON:0002036,3.38e-13,9;UBERON:0002385,3.38e-13,9;UBERON:0000486,3.38e-13,9;UBERON:0007503,3.38e-13,9;UBERON:0001015,3.38e-13,9;UBERON:0002329,3.38e-13,9;UBERON:0003082,3.38e-13,9;UBERON:0003059,3.38e-13,9;UBERON:0007282,3.38e-13,9;UBERON:0004290,3.38e-13,9;UBERON:0009618,3.38e-13,9;UBERON:0000383,5.96e-12,10;UBERON:0007524,6.27e-11,11;UBERON:0003077,6.27e-11,11;UBERON:0007285,6.27e-11,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.95210098400125,4.6880120671428,9.94695113550217,9.99993529652724,6.14740936462601,8.25367600152961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.884610551949874,0,0,0,0,0,0,0,0.11981512450592,0.599902730993408,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.28673953557358,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.287696137450811,0.162135226775035,0.274561413188081,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100826185136841,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p6@Trem3 | |||
}} |
Latest revision as of 15:02, 26 September 2015
Short description: | p6@Trem3 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_6_at_Trem3_5end |
Coexpression cluster: | MCL_coexpression_mm9:3 |
Association with transcript: | -25bp_to_ENSMUST00000048065, NM_021407, uc008cwy.1_5end |
EntrezGene: | Trem3 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 3.38e-13 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 3.38e-13 | 9 |
striated muscle tissue | 3.38e-13 | 9 |
muscle tissue | 3.38e-13 | 9 |
multilaminar epithelium | 3.38e-13 | 9 |
epithelial vesicle | 3.38e-13 | 9 |
musculature | 3.38e-13 | 9 |
somite | 3.38e-13 | 9 |
myotome | 3.38e-13 | 9 |
presomitic mesoderm | 3.38e-13 | 9 |
presumptive segmental plate | 3.38e-13 | 9 |
dermomyotome | 3.38e-13 | 9 |
trunk paraxial mesoderm | 3.38e-13 | 9 |
musculature of body | 5.96e-12 | 10 |
dense mesenchyme tissue | 6.27e-11 | 11 |
paraxial mesoderm | 6.27e-11 | 11 |
presumptive paraxial mesoderm | 6.27e-11 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 6.64e-38 | 3 |
muscle cancer | 6.64e-38 | 3 |
organ system cancer | 2.11e-19 | 6 |